Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

CounterPath Q2 EPS $0.04 Up From $(0.12) YoY, Sales $3.60M Up From $2.70M YoY

Author: Benzinga Newsdesk | December 14, 2020 08:48am
CounterPath (NASDAQ:CPAH) reported quarterly earnings of $0.04 per share. This is a 133.33 percent increase over losses of $(0.12) per share from the same period last year. The company reported $3.60 million in sales this quarter. This is a 33.28 percent increase over sales of $2.70 million the same period last year.

Posted In: CPAH